Literature DB >> 19452386

Obesity hypoventilation syndrome.

Kenneth I Berger1, Roberta M Goldring, David M Rapoport.   

Abstract

The term obesity hypoventilation syndrome (OHS) refers to the combination of obesity and chronic hypercapnia that cannot be directly attributed to underlying cardiorespiratory disease. Despite a plethora of potential pathophysiological mechanisms for gas exchange and respiratory control abnormalities that have been described in the obese, the etiology of hypercapnia in OHS has been only partially elucidated. Of particular note, obesity and coincident hypercapnia are often associated with some form of sleep disordered breathing (apnea/hypopnea or sustained periods of hypoventilation). From a conceptual point of view, even transient reductions of ventilation from individual sleep disordered breathing events must produce acute hypercapnia during the period of low ventilation. What is less clear, however, is the link between these transient episodes of acute hypercapnia and the development of chronic sustained hypercapnia persisting into wakefulness. A unifying view of how this comes about is presented in the following review. In brief, our concept is that chronic sustained hypercapnia (as in obesity hypoventilation) occurs when the disorder of ventilation that produces acute hypercapnia interacts with inadequate compensation (both during sleep and during the periods of wakefulness); neither alone is sufficient to fully explain the final result. The following discussion will amplify on both the potential reasons for acute hypercapnia in the obese and on what is known about the failure of compensation that must occur in these subjects.

Entities:  

Mesh:

Year:  2009        PMID: 19452386     DOI: 10.1055/s-0029-1222439

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  11 in total

Review 1.  Respiratory management of the obese patient undergoing surgery.

Authors:  Luke E Hodgson; Patrick B Murphy; Nicholas Hart
Journal:  J Thorac Dis       Date:  2015-05       Impact factor: 2.895

2.  Obesity Hypoventilation Syndrome: Early Detection of Nocturnal-Only Hypercapnia in an Obese Population.

Authors:  Sheila Sivam; Brendon Yee; Keith Wong; David Wang; Ronald Grunstein; Amanda Piper
Journal:  J Clin Sleep Med       Date:  2018-09-15       Impact factor: 4.062

3.  A quantile regression approach to re-investigate the relationship between sleep duration and body mass index in Taiwan.

Authors:  Chiang-Ming Chen; Chen-Kang Chang; Chia-Yu Yeh
Journal:  Int J Public Health       Date:  2011-02-15       Impact factor: 3.380

Review 4.  Chronic hypoventilation syndromes and sleep-related hypoventilation.

Authors:  Sebastian Böing; Winfried J Randerath
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

5.  Obesity Hypoventilation Syndrome and Anesthesia.

Authors:  Edmond H L Chau; Babak Mokhlesi; Frances Chung
Journal:  Sleep Med Clin       Date:  2012-12-14

Review 6.  Respiratory mechanics and ventilatory control in overlap syndrome and obesity hypoventilation.

Authors:  Johan Verbraecken; Walter T McNicholas
Journal:  Respir Res       Date:  2013-11-20

7.  Frequency and predictors of obesity hypoventilation in hospitalized patients at a tertiary health care institution.

Authors:  Yilmaz Bülbül; Sibel Ayik; Tevfik Ozlu; Asim Orem
Journal:  Ann Thorac Med       Date:  2014-04       Impact factor: 2.219

8.  Correlates of obesity-related chronic ventilatory failure.

Authors:  Ari R Manuel; Nicholas Hart; John R Stradling
Journal:  BMJ Open Respir Res       Date:  2016-02-18

9.  The clinical characteristics and hospital and post-hospital survival of patients with the obesity hypoventilation syndrome: analysis of a large cohort.

Authors:  P E Marik; C Chen
Journal:  Obes Sci Pract       Date:  2016-02-09

10.  Ventilatory response to exercise is preserved in patients with obesity hypoventilation syndrome.

Authors:  Teng Han; Li Zhang; Chun Yan Yu; Yi Ming Li; Yan Wang; Xiao Lei Zhang
Journal:  J Clin Sleep Med       Date:  2020-12-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.